CD8A and neoplasm: Of note, IL-1α–engineered tumor cells rarely develop into tumors, and if they do, the tumors are quickly destroyed through a mechanism that involves CD8+ T cells and natural killer cells, and IL-1α enhances immunoediting in the tumor microenvironment.36